Stamford, CT, April 1, 2022 – ApiJect Systems, Corp., a medical technology company that seeks to revolutionize how medicines and vaccines are filled, finished, and delivered, is pleased to announce the expansion of the Company’s executive leadership team. ApiJect welcomes Russell (Bo) Kowalczyk as Senior Vice President of Commercial Development.
Mr. Kowalczyk brings to the company extensive experience in business development, strategic planning, sales and operation planning, and relationship building. Throughout his career, he has demonstrated success developing sales teams who provide superior service and is committed to creating a differentiating experience for pharmaceutical and device relationships.
Mr. Kowalczyk commented: “ApiJect is a growing company, with an exciting mission and a great team of pharmaceutical leaders. I am very excited to have the opportunity to help the company achieve its goals.”
Mr. Kowalczyk continued: “ApiJect is a company well-positioned to grow rapidly. It’s soon to be launched Technology Center in greater Orlando, Florida, gives the company a unique edge in terms of narrowing the timeline between innovation in fill, finish and product commercialization. I join a very talented team of business development professionals and am eager to focus on strategic initiatives to support our customers and the industries we serve.”
Jay Walker, ApiJect CEO, stated: “Bo has been a leader and a winner throughout his career in Pharma. He brings a strong track record of success in growing company revenues and managing effectively and efficiently the sales function of his previous companies. We are fortunate to have him on our team.”
Prior to joining ApiJect, Mr. Kowalczyk served as the Vice President of Sales, North America, for Syngene International’s Chemical Development and Manufacturing division, where he aligned operational expertise with prospecting efforts to target the right opportunities and maximize client satisfaction. He served as Global VP, Business Development and Marketing with Eurofins Biologics Bioanalytical Services where he led efforts to integrate Bioanalytical Services with Eurofins Central Lab Services to provide seamless services for clinical trial logistics and sample testing support. He served as Vice President, Business Development and Marketing at AIT Bioscience where he successfully grew sales & profitability over a 5 year period in part by creating a network of 3rd party preclinical toxicology service providers allowing AIT Bioscience earlier access to promising therapeutic candidates moving into clinical trials.
Mr. Kowalczyk holds an undergraduate degree from DePaul University, a Master of Science Degree from Illinois Institute of Technology, and an MBA in Marketing and Management from the University of Illinois.
ABOUT APIJECT SYSTEMS
ApiJect Systems, Corp. is a public-benefit medical technology company working to bring prefilled, single-dose injections to more people in every market. The ApiJect Platform enables pharmaceutical and biotech companies to design scalable prefilled injectors and efficiently fill-finish them with their injectable drug products. This can be done either on one of their own ApiJect-licensed Blow-Fill-Seal packaging lines or at one of our world-class manufacturing partners. Contact Steve Hofman at email@example.com